Adragos Pharma, a contract development & manufacturing organization (CDMO), has enhanced its production capabilities with the completion of a new ampoule filling line at its Livron-sur-Drôme site in France.   Adragos invested €13 million ($13.8 million) to boost the facility’s output by 30%, enabling the company to manufacture over 160 million ampoules annually and meet the growing demand in global pharmaceutical markets for sterile injectables.   The newly installed line, now the fourth...